添加微信 添加微信
添加微信
首页: 全球医药政策

美国-ChemDiv

时间:2021-10-21 19:24:56 来源:康安医药咨询 作者:康安医药咨询

ChemDiv, a fully Integrated Target-to-Clinic Contract Research Organization (CRO) headquartered in San Diego, CA USA, has been a pioneer in discovery libraries since 1991. Its first diverse heterocyclic compounds collection was compiled from academic lab sources from all over the world, and ChemDiv subsequently successfully launched its own large-scale library synthesis program. ChemDiv is now the recognized global leader in discovery chemistry with the industry’s largest, most diverse, and most pharmacologically-relevant commercial collection of over 1,500,000 individually crafted, lead-like, drug-like small molecules. ChemDiv executes pre-clinical chemistry and biology for drug development and clinical trials for an international portfolio of companies across the entire range of targets with small molecule and biotech drugs. The company operates multiple research and development (R&D) subsidiaries in Russia, Ukraine and China as well as business operations around the world. Our laboratories are equipped for both ‘GLP-like’ and GLP research standards to meet our international research and business partners’ needs. We custom-tailor our professional assistance to best meet your R&D Chemistry, Biology and Clinical needs. We pride ourselves on being one of the industry’s most experienced CROs, with hands-on expertise in every aspect of both early and clinical development of anti-infectives and antivirals, oncologics, CNS, cardiometabolics, and anti-inflammatory therapies. Our track record spans successful and timely delivery of discovery libraries, target-biased compound sets reflective of modern trends in Chemical Biology, pathway analysis, in vitro/ex vivo and in vivo assay development and implementation, as well as a multitude of modern drug discovery and evaluation platforms all aimed at accelerated cost-effective R&D. Our integrated Discovery outSourceTM solutions cover all disciplines needed to bring a project from target ID to Phase III clinical candidate and beyond.

Phone: 1, 858-794-4860 Fax: 1, 858-794-4931 E-mail: chemdiv@chemdiv.com
Web: https://www.chemdiv.com
Add:12760 High Bluff Drive, Suite 370,San Diego, CA 92130

想要下载更多资料,请您添加微信了解详情!

微信号:csco2022

公众号:康安医药咨询

当前栏目

频道栏目

最新文章

热门文章